“…SALL2 also contributes to cellular apoptosis, growth arrest, and quiescence maintenance by regulation of multiple downstream genes, such as p21Cip1/Waf1, p16Ink4a, c-MYC, BAX, and Noxa (Dawei Li et al, 2004;Gu et al, 2011;Sung et al, 2012;Escobar et al, 2015;Wu et al, 2015). Recently, SALL2 was found downregulated in various types of cancer, including leukemia, ovarian, lung, and radioresistant esophageal cancers (Sung et al, 2013;Liu et al, 2014;Luo et al, 2017), suggesting that SALL2 may act as a tumor suppressor. However, Suva et al (2014) found that SALL2 may also function as an oncogene, as it contributed to converting differentiated glioblastoma cells into cancer stem-like cells, thus favoring glioblastoma propagation.…”